Cleared Traditional

K862916 - EZ-SCREEN: CANNABINOID

K862916 is an FDA 510(k) clearance for EZ-SCREEN: CANNABINOID, manufactured by Environmental Diagnostics, Inc.. The device is a Class 2 Toxicology device with product code KLT cleared through the Traditional 510(k) pathway after a 159-day FDA review.

K862916 · Environmental Diagnostics, Inc. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1987
Decision
159d
Days
Class 2
Risk

K862916 is an FDA 510(k) clearance for the EZ-SCREEN: CANNABINOID. Classified as Enzyme Immunoassay, Carbamazepine (product code KLT), Class II - Special Controls.

Submitted by Environmental Diagnostics, Inc. (Burlington, US). The FDA issued a Cleared decision on January 7, 1987 after a review of 159 days - an extended review cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3645 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.

View all Environmental Diagnostics, Inc. devices

FDA 510(k) Submission Details - K862916

510(k) Number K862916 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 01, 1986
Decision Date January 07, 1987
Days to Decision 159 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
72d slower than avg
Panel avg: 87d · This submission: 159d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KLT Device Classification - Class 2, Special Controls

Product Code KLT Enzyme Immunoassay, Carbamazepine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3645
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - KLT Enzyme Immunoassay, Carbamazepine

All 53
Devices cleared under the same product code (KLT) and FDA review panel - the closest regulatory comparables to K862916.
EMIT CARBAMAZEPINE ASSAY
K871306 · Syva Co. · Apr 1987
SERALYZER ARIS CARBAMAZEPINE STRIPS/MODU/CALI/CONT
K863842 · Miles Laboratories, Inc. · Jan 1987
EASY-TEST CARBAMAZEPINE ITEM NO. 67---/95
K864553 · Em Diagnostic Systems, Inc. · Jan 1987
DETERMINATION OF CARBAMAZEPINE
K860047 · Clinical Data, Inc. · Jan 1986
EMIT QST CARBAMAZEPINE ASSAY
K853835 · Syva Co. · Oct 1985
COBAS FP REAGENTS FOR CARBAMAZEPINE
K850807 · Roche Diagnostic Systems, Inc. · Mar 1985